Satellos Bioscience Common Stock Overview

Satellos Bioscience Common Stock Operating Income

Satellos Bioscience Common Stock's operating income is $-30M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-9903887.00

As of Mar 31, 2026

Annual Operating Income (TTM)

$-29883887.00

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

Satellos Bioscience Common Stock (MSLE) FAQ

Satellos Bioscience Common Stock (MSLE) currently reports a operating income of $-30M as of March 2026. Use the charts on this page to explore Satellos Bioscience Common Stock's operating income history and peer comparisons.

Satellos Bioscience Common Stock reported $-30M in operating income as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-30M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Satellos Bioscience Common Stock, and consider following MSLE for alerts when major investors trade the stock.